Lindbrook Capital’s Sorrento Therapeutics, Inc. SRNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-941
| Closed | -$1K | – | 3085 |
|
|
2022
Q3 | $1K | Sell |
941
-115
| -11% | -$122 | ﹤0.01% | 2583 |
|
|
2022
Q2 | $2K | Buy |
+1,056
| New | +$2K | ﹤0.01% | 2109 |
|
|
2022
Q1 | – | Sell |
-8,481
| Closed | -$39K | – | 2668 |
|
|
2021
Q4 | $39K | Buy |
8,481
+8,134
| +2,344% | +$37.4K | 0.01% | 805 |
|
|
2021
Q3 | $3K | Hold |
347
| – | – | ﹤0.01% | 1473 |
|
|
2021
Q2 | $3K | Hold |
347
| – | – | ﹤0.01% | 1532 |
|
|
2021
Q1 | $3K | Sell |
347
-96
| -22% | -$830 | ﹤0.01% | 1483 |
|
|
2020
Q4 | $3K | Buy |
443
+14
| +3% | +$95 | ﹤0.01% | 1395 |
|
|
2020
Q3 | $5K | Sell |
429
-62
| -13% | -$723 | ﹤0.01% | 1140 |
|
|
2020
Q2 | $3K | Buy |
491
+144
| +41% | +$880 | ﹤0.01% | 1323 |
|
|
2020
Q1 | $1K | Buy |
+347
| New | +$1K | ﹤0.01% | 1625 |
|